Novel polysaccharides-based nanoparticle carriers prepared by polyelectrolyte complexation for protein drug delivery

Polymer Bulletin

Volumn 68, Issue 4, 2012, Pages 1183-1199

  Hu, Yan ^a   Yang, Tianming ^a   Hu, Xianming ^b  

^a SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Carboxymethyl pachyman; Chitosan; Nanoparticles; Polyelectrolyte complexation

Indexed keywords

AVERAGE PARTICLE SIZE; BOVINE SERUM ALBUMINS; CARBOXYMETHYL; DELIVERY SYSTEMS; EFFECT FACTORS; ENCAPSULATION EFFICIENCY; LOADING CONCENTRATION; MEAN PARTICLE SIZE; NANO PARTICULATES; NATURAL POLYSACCHARIDE; NEW APPLICATIONS; OPTIMIZED CONDITIONS; ORAL PROTEIN DELIVERY; PARTICLE FORMATIONS; PHYSICOCHEMICAL PROPERTY; POLYELECTROLYTE COMPLEXATION; POSITIVELY CHARGED; PREPARATION CONDITIONS; PROTEIN DRUG DELIVERY; PROTEIN DRUGS; TRANSMISSION ELECTRON MICROSCOPE;

CHITOSAN; DRUG DELIVERY; ENCAPSULATION; POLYSACCHARIDES; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

NANOPARTICLES;

EID: 84859589925     PISSN: 01700839     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00289-011-0683-9     Document Type: Article

References (48)

1. Qiu B, Stefanos S, Ma J, Lalloo A, Perry BA, Leibowitz MJ, Sinko PJ, Stein S (2003) A hydrogel prepared by in situ cross-linking of a thiol-containing poly(ethylene glycol)-based copolymer: a new biomaterial for protein drug delivery. Biomaterials 24:11-18 (Pubitemid 35300198)
2. George M, Abraham TE (2007) pH sensitive alginate-guar gum hydrogel for the controlled delivery of protein drugs. Int J Pharm 335:123-129 (Pubitemid 46482870)
3. Ponchel G, Irache JM (1998) Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Drug Delivery Rev 34:191-219 (Pubitemid 28535112)
4. Russell-Jones GJ (2000) Oral vaccine delivery. J Controlled Release 2000(65):49-54 (Pubitemid 30122914)
5. Wang W (1996) Oral protein drug delivery. J Drug Target 4:195-232 (Pubitemid 26421822)
6. Kompella UB, Lee VH (2001) Delivery systems for penetration enhancement of peptide and protein drugs: design considerations. Adv Drug Deliv Rev 46:211-245 (Pubitemid 33653423)
7. des Rieux A, Fievez V, Garinot M, Schneider YJ, Proeat V (2006) Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 116:1-27 (Pubitemid 44792295)
8. Chen F, Zhang ZR, Yuan F, Qin X, Wang M, Huang Y (2008) In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery. Int J Pharm 349:226-233 (Pubitemid 350299699)
9. Lowe PJ, Temple CS (1994) Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats. J Pharm Pharmacol 46:547-552 (Pubitemid 24213278)
10. Janes KA, Calvo P, Alonso MJ (2001) Polysaccharide colloidal particles as delivery systems for macromolcules. Adv Drug Del Rev 47:57-83
11. Gullberg E, Leonard M, Karlsson J, Hopkins AM, Brayden D, Baird AW, Artursson P (2000) Expression of specific markers and particle transport in a new human intestinal M-cell model. Biochem Biophys Res Commun 279:808-813 (Pubitemid 32042860)
12. Galindo-Rodriguez SA, Allemann E, Fessi H, Doelker E (2005) Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. Crit Rev Ther Drug Carrier Syst 22:419-464
13. Clark MA, Blair H, Liang L, Brey RN, Brayden D, Hirst BH (2001) Targeting polymerised liposome vaccine carriers to intestinal M cells. Vaccine 20:208-217 (Pubitemid 32905334)
14. Zhang XG, Teng DY, Wu ZM, Wang X, Wang Z et al (2008) PEG-grafted chitosan nanoparticles as an injectable carrier for sustained protein release. J Mater Sci Mater Med 19:3525-3533
15. Mao H, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y et al (2001) Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Rel 70:399-421 (Pubitemid 32155463)
16. Silva DA, Maciel JS, Feitosa JPA, Paula HCB, de Paula RCM (2010) Polysaccharide-based nanoparticles formation by polyeletrolyte complexation of carboxymethylated cashew gum and chitosan. J Mater Sci 45:5605-5610
17. Mao S, Bakowsky U, Kissel T (2006) Self assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin. J Pharm Sci 95:1035-1048 (Pubitemid 43723163)
18. Shu S, Zhang X, Teng Dg, Wang Z, Li C (2009) Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release. Carbohydr Res 344:1197-1204
19. Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z (2008) Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Del Rev 60:1650-1662
20. Krylova E, Ivanov A, Orlovski V, El-Registan G, Barinov S (2002) Hydroxypatite-polysaccharide granules for drug delivery. J Mater Sci Mater Med 13:87-90 (Pubitemid 34145359)
21. Zhang H, Wu C, Zhang Y, White CJB, Xue Y, Nie H, Zhu L (2010) Elaboration, characterization and study of a novel affinity membrane made from electrospun hybrid chitosan/nylon-6 nanofibers for papain purification. J Mater Sci 45:2296-2304
22. Chen F, Zhang ZR, Huang Y (2007) Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers. Int J Pharm 336:166-173 (Pubitemid 46551555)
23. Felt O, Buri P, Gurny R (1998) Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm 24:979-993 (Pubitemid 28460237)
24. Onishi H, Machida Y (1999) Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 20:175-182 (Pubitemid 29041345)
25. Lee KY, Ha WS, Park WH (1995) Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. Biomaterials 16:1211-1216
26. Bernkop-Schurch A, Humenberg C, Valenta C (1998) Basic Studies on bioadhesive delivery systems for peptide and protein drugs. Int J Pharm 165:217-225 (Pubitemid 28239708)
27. van der Lubben IM, Kersten G, Fretz MM, Beuvery C, Verhoef JC, Junginger HE (2003) Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine 28:1400-1408 (Pubitemid 36263181)
28. Artursson P, Lindmark T, Davis S, Illum L (1994) Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 11:1358-1361 (Pubitemid 24287420)
29. Wang L, Wang A (2007) Adsorption characteristics of Congo Red onto the chitosan/montmorillonite nanocomposite. J Hazard Mater 147:979
30. Tang Y, Zhao Y, Li Y, Du Y (2010) A thermosensitive chitosan/poly(vinyl alcohol) hydrogel containing nanoparticles for drug delivery. Polym Bull 64:791-804
31. Chihara G, Hamuro J, Maeda Y, Arai Y, Fukuoka F (1970) Antitumour polysaccharide derived chemically from natural glucan (pachyman). Nature 225:943-944
32. Wang YF, Zhang M, Ruan D, Shashkov AS, Kilcoyne M, Savage AV, Zhang L (2004) Chemical components and molecular mass of six polysaccharides isolated from the sclerotium of Poria cocos. Carbohydr Res 339:327-334 (Pubitemid 38041138)
33. Narui T, Takahashi K, Kobayashi M, Shibata S (1980) A polysaccharide produced by laboratory cultivation of Poria cocos wolf. Carbohydr Res 87:161-163
34. Yamada H, Kiyohara H, Takemoto N, Zhao JF, Kawamura H, Komatsu Y, Cyong JC, Aburada M, Hosoya E (1992) Studies on immunologically active substances from kampo medicine, juzen-taihoto. 3. Mitogenic and complement activating activities of the herbal components of juzentaiho-to. Planta Med 58:166-170
35. Schinella GR, Tournier HA, Prieto JM, Mordujovich de Buschiazzo P, Rios JL (2002) Antioxidant activity of anti-inflammatory plant extracts. Life Sci 70:1023-1033 (Pubitemid 34085094)
36. Wang SX, Wen YY, Hu CX (1995) Immunoactivities of the polysaccharides from Morus-alba, Chlamydomonas-mexicana and Poria-cocos. Phytother Res 9:448-451
37. Hu Y, Zhou X, Lu Y, Hu C, Hu X (2008) Novel biodegradable hydrogels based on pachyman and its derivatives for drug delivery. Int J Pharm 371:89-98
38. Hamuro J, Yamashita Y, Ohsaka Y, Maeda YY, Chihara G (1971) Carboxymethylpachymaran, a new water soluble polysaccharide with marked antitumour activity. Nature 233:486-487
39. Wang YF, Zhang LN, Li YQ, Hou XH, Zeng FB (2004) Correlation of structure to antitumor activities of five derivatives of a b-glucan from Poria cocos sclerotium. Carbohydr Res 339:2567-2574
40. Hu Y, He XR, Lei L, Liang SC, Qiu GF, Hu XM (2008) Preparation and characterization of self-assembled nanoparticles of the novel carboxymethyl pachyman-deoxycholic acid conjugates. Carbohydr Polym 74:220-227
41. Xiao YL, Liang SC, Qiu GF, Wu JY, Zhang JB, Hu XM (2007) Preparation, characterization and tableting properties of two new pachyman-based pharmaceutical aids: I. Disintegrants in dispersible tablets. Polym Advan Technol 18:268-274
42. Wang YF, Zhang LN, Ruan D (2004) Preparation and structure of five derivatives of b-(1-3)- D-glucan isolated from Poria cocos sclerotium. Chin J Polym Sci 22:137-145 (Pubitemid 350168404)
43. Eyler RW, Klug ED, Diephuis F (1947) Determination of degree of substitution of sodium carboxymethylcellulose. Anal Chem 19:24-27
44. Tian F, Liu Y, Hu K, Zhao BY (2004) Study of the depolymerization behavior of chitosan by hydrogen peroxide. Carbohydr Polym 57:31-37
45. Liu Z, JiaoY LiuF, Zhang Z (2007) Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation. J Biomed Materi Res Part A 83A:806-812 (Pubitemid 350086307)
46. Roberts GAF, Domszy JG (1982) Determination of the viscometric constants for chitosan. Int J Biol Macromol 4:374-377
47. Bayat A, Dorkoos FA, Dehpour AR, Moezi L, Larijani B, Junginger HE, Rafiee-Tehrani M (2008) Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies. Int J Pharm 356:259-266
48. John MW (2002) The protein protocols handbook, 2nd edn. Humana Press Inc., New Jersey, p 15.